Last updated 2026-09-07
- Raised $100M Public Offering, Aug 2021
- Raised $100M Public Offering, Feb 2014
- Raised $26M Public Offering, Feb 2026
Total raised
$495.9M
Last: PIPE 2026-06
Stage
Public
Founded
2009
Headcount
13
HQ
Tel Aviv-Yafo, Israel
Sector
Pharmaceuticals
About
RedHill Biopharma Ltd. is a specialty biopharmaceutical company primarily focused on the development and commercialization of proprietary, orally-administered small molecules for the treatment of inflammatory, gastrointestinal and oncology indications. The company's mission is to deliver extraordinary medicines that help people live extraordinary lives. RedHill has a robust development pipeline with multiple R&D programs and established commercial operations in the U.S..
Funding history · 22 rounds · $495.9M total
22 events/rounds · $495.9M Total Funding: $5.0M in Private Equity, $480.9M in Public Equity
Jul 2026
Public Offering
$13.8M
EDGAR filing SEC-EDGAR 424B3
Feb 2026
Public Offering
$26.0M
EDGAR filing SEC-EDGAR 424B3
Nov 2025
Jul 2025
Public Offering
$10.0M
EDGAR filing SEC-EDGAR 424B3
Feb 2025
Public Offering
$3.5M
EDGAR filing SEC-EDGAR 424B5
Apr 2024
Public Offering
$1.2M
EDGAR filing SEC-EDGAR 424B5
Oct 2023
Public Offering
$2.0M
EDGAR filing SEC-EDGAR 424B3
Apr 2023
Public Offering
$6.0M
EDGAR filing SEC-EDGAR 424B5
Dec 2022
Public Offering
$8.0M
EDGAR filing SEC-EDGAR 424B5
Nov 2021
Public Offering
$15.0M
EDGAR filing SEC-EDGAR 424B5
Aug 2021
Public Offering
$100.0M
EDGAR filing SEC-EDGAR 424B3
Jul 2019
Public Offering
$60.0M
EDGAR filing SEC-EDGAR 424B5
Dec 2018
Public Offering
$20.0M
EDGAR filing SEC-EDGAR 424B5
Aug 2018
Public Offering
$25.0M
EDGAR filing SEC-EDGAR 424B5
Nov 2017
Public Offering
$22.5M
EDGAR filing SEC-EDGAR 424B5
Dec 2016
Public Offering
$15.0M
EDGAR filing SEC-EDGAR 424B5
Jul 2015
Public Offering
$40.0M
EDGAR filing SEC-EDGAR 424B5
Feb 2015
Public Offering
$12.5M
EDGAR filing SEC-EDGAR 424B5
Feb 2014
Public Offering
$100.0M
EDGAR filing SEC-EDGAR 424B3
Dec 2012
B Round
Undisclosed
tracxn.com
Nov 2010
A Round
Undisclosed
tracxn.com
May 2010
★ ProSeed Capital Holdings
Headcount over time
13 employees (2026-09) · 1 point
Offices
Tel Aviv-Yafo, Israel · HQ / main office
Q&A
- What is RedHill Biopharma's primary focus?
- RedHill Biopharma is a specialty biopharmaceutical company focused on the development and commercialization of proprietary, orally-administered small molecules for the treatment of inflammatory, gastrointestinal, and oncology indications.
- When was RedHill Biopharma founded?
- RedHill Biopharma was founded in 2009.
- What is the current employee count for RedHill Biopharma?
- RedHill Biopharma currently has 13 employees, which falls into the 11-50 employee bucket.
- What was RedHill Biopharma's most recent funding round?
- RedHill Biopharma completed a PIPE funding round in June 2026, raising $6,000,000.
- What is the total amount of funding RedHill Biopharma has raised to date?
- RedHill Biopharma has raised a total of $72,500,000.
- What is RedHill Biopharma's current operational status?
- RedHill Biopharma is a public company.
- Where is RedHill Biopharma headquartered?
- RedHill Biopharma is headquartered in Tel Aviv-Yafo, Israel.
- Who is a co-founder of RedHill Biopharma?
- Dror Ben-Asher is a co-founder of RedHill Biopharma.
Team · 17
Dror Ben-Asher
Founder · CEO & Chairman
Razi Ingber
CFO
Adi Frish
Chief Corporate & Business Development Officer
Gilead Raday
Chief Operating Officer
Rick D. Scruggs
President, RedHill Biopharma Inc. & Chief Commercial Officer
Guy Goldberg
Chief Business Officer
Mark L. Levitt
Chief Scientific Officer
Reza Fathi
Senior VP R&D
Shmuel Cabilly
Independent Director
Kenneth Reed
Independent Director
Ofer Tsimchi
Independent Director
Roni Mamluk
Independent Director
Prof. Ran Oren
Advisory Board Member
Prof. Chezy Barenholz
Advisory Board Member
Dr. Jerry Rosenblatt
Advisory Board Member
Dr. Ira Kalfus
Advisory Board Member
Dr. Werner Tschollar
Advisory Board Member
Sectors & technology
Primary sector
Pharmaceuticals
Target customers
Business model
B2C
Highlights
Patents
Tags
inflammatory-diseasescrohn-s-diseasebiopharmaceuticaloral-drugsmedical-productsgastroenterologypharmaceuticalsoncologyhealthcare-providersorphan-drugpatientsinfectious-disease
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | redhillbio.com |
|---|---|
| linkedin.com/company/2259672 | |
| X / Twitter | twitter.com/RedHillBio |
Identifiers & details
| Legal name | RedHill Biopharma Ltd. |
|---|---|
| Founded | 2009 |
| Employees (exact) | 13 |
Radar intelligence
Patents
| EPO | 16 |
|---|
Web history (Wayback)
| Domain | redhillbio.com |
|---|
Certificate / subdomain footprint
| Subdomains | 4 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514304005 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה ציבורית |
| Incorporated | 2009-08-03 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 9 — violation (1), annual_report (6), people (1), charge (1) |
| Registered address | הארבעה 21 תל אביב - יפו |
Recent registry events
| Date | Event |
|---|---|
| 2026-05-26 | עדכון הפרה |
| 2026-06-17 | דו~ח שנתי-עדכון כתובת |
| 2026-06-17 | דו~ח שנתי-שינוי בהוראות בתקנון |
| 2026-06-17 | דו~ח שנתי-הוספת בעל תפקיד |
| 2026-06-17 | דו~ח שנתי-עדכון תחום עיסוק |
| 2026-06-17 | דו~ח שנתי-עדכון מען דיגיטלי |
| 2026-06-17 | דו~ח שנתי-הגדלת הון |
| 2026-02-09 | עדכון דירקטורים-הסרת דירקטור |
| 2026-05-04 | עדכון שעבוד |